Nipro Corporation (TYO:8086)

Japan · Delayed Price · Currency is JPY

1,606.00

+14.50 (0.91%)

Aug 5, 2026, 3:30 PM JST

14.71% (1Y)

Market Cap	264.01B +15.6%
Revenue (ttm)	660.54B +2.5%
Net Income	13.50B +164.1%
EPS	73.36 +164.1%
Shares Out	164.39M
PE Ratio	21.89
Forward PE	17.31
Dividend	32.00 (2.01%)
Ex-Dividend Date	Sep 29, 2026

Volume	389,100
Open	1,606.50
Previous Close	1,591.50
Day's Range	1,595.00 - 1,609.00
52-Week Range	1,367.50 - 1,760.50
Beta	-0.00
Analysts	Buy
Price Target	1,986.00 (+23.66%)
Earnings Date	Aug 10, 2026

About Nipro

Nipro Corporation, together with its subsidiaries, engages in the medical devices, pharmaceuticals, and pharma packaging businesses. Its Medical-Related business develops, manufactures, and sells injection and infusion products, artificial organ-related products, functional products, dialysis products, cell cultures, hospital products, diabetic products, and pharmaceuticals comprising generic and kit products; and manufactures medical equipment, including dialysis medical device products; and operates dialysis and training centers. The company’... [Read more]

Industry Medical Instruments & Supplies

Sector Healthcare

Founded 1947

Employees 38,593

Stock Exchange Tokyo Stock Exchange

Ticker Symbol 8086

Full Company Profile

Financial Performance

In fiscal year 2026, Nipro's revenue was 660.54 billion, an increase of 2.47% compared to the previous year's 644.59 billion. Earnings were 13.50 billion, an increase of 164.11%.

Financial Statements

Analyst Summary

According to 5 analysts, the average rating for 8086 stock is "Buy." The 12-month stock price target is ¥1,986, which is an increase of 23.66% from the latest price.

Price Target

¥1,986

(23.66% upside)

Analyst Consensus: Buy

Stock Forecasts